Professor Mark Febbraio is a Senior Principal Research Fellow of the NHMRC and Head of the Division of Diabetes & Metabolism at The Garvan Institute of Medical Research in Sydney, Australia. He is also the Chief Scientific Officer of N-Gene Research Laboratories Inc., a USA based Biotechnology Company. His research is focussed on understanding cellular and molecular mechanisms associated obesity, inflammation, and related diseases such as type 2 diabetes and cancer and his research is geared towards developing novel drugs to treat such diseases. He has authored over 220 peer reviewed papers in leading journals and has over 20,000 career citations. He has won prizes at international, national and institutional levels. Professor Febbraio is also dedicated to health and fitness and continues to compete in multi-sport endurance events.
« Go Back